These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23675295)

  • 1. Volatile metabolites of pathogens: a systematic review.
    Bos LD; Sterk PJ; Schultz MJ
    PLoS Pathog; 2013 May; 9(5):e1003311. PubMed ID: 23675295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
    Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas Chromatography-Mass Spectrometry Profiling of Volatile Metabolites Produced by Some
    Koilybayeva M; Shynykul Z; Ustenova G; Waleron K; Jońca J; Mustafina K; Amirkhanova A; Koloskova Y; Bayaliyeva R; Akhayeva T; Alimzhanova M; Turgumbayeva A; Kurmangaliyeva G; Kantureyeva A; Batyrbayeva D; Alibayeva Z
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005278
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry.
    Chen J; Tang J; Shi H; Tang C; Zhang R
    J Basic Microbiol; 2017 Mar; 57(3):228-237. PubMed ID: 27874211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant/susceptible classification of respiratory tract pathogenic bacteria based on volatile organic compounds profiling.
    Karami N; Rezadoost H; Mirzajani F; Karimi A; Ghassempour A; Aliahmadi A; Fallah F
    Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):6-15. PubMed ID: 30030949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
    Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
    J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
    Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
    J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of volatile metabolites during growth of Escherichia coli and Pseudomonas aeruginosa by needle trap-GC-MS.
    Zscheppank C; Wiegand HL; Lenzen C; Wingender J; Telgheder U
    Anal Bioanal Chem; 2014 Oct; 406(26):6617-28. PubMed ID: 25146358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients.
    Ahmed WM; Fenn D; White IR; Dixon B; Nijsen TME; Knobel HH; Brinkman P; Van Oort PMP; Schultz MJ; Dark P; Goodacre R; Felton T; Bos LDJ; Fowler SJ;
    Clin Infect Dis; 2023 Mar; 76(6):1059-1066. PubMed ID: 36310531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TD/GC-MS analysis of volatile markers emitted from mono- and co-cultures of
    Lawal O; Knobel H; Weda H; Nijsen TME; Goodacre R; Fowler SJ;
    Metabolomics; 2018; 14(5):66. PubMed ID: 29725275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infections.
    Abd El Qader A; Lieberman D; Shemer Avni Y; Svobodin N; Lazarovitch T; Sagi O; Zeiri Y
    Biomed Chromatogr; 2015 Dec; 29(12):1783-90. PubMed ID: 26033043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.
    Boots AW; Smolinska A; van Berkel JJ; Fijten RR; Stobberingh EE; Boumans ML; Moonen EJ; Wouters EF; Dallinga JW; Van Schooten FJ
    J Breath Res; 2014 Jun; 8(2):027106. PubMed ID: 24737039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled Volatile Organic Compounds of Infection: A Systematic Review.
    Ahmed WM; Lawal O; Nijsen TM; Goodacre R; Fowler SJ
    ACS Infect Dis; 2017 Oct; 3(10):695-710. PubMed ID: 28870074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry.
    Zhu J; Bean HD; Kuo YM; Hill JE
    J Clin Microbiol; 2010 Dec; 48(12):4426-31. PubMed ID: 20962140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro profiling of volatile organic compounds released by Simpson-Golabi-Behmel syndrome adipocytes.
    Mochalski P; Diem E; Unterkofler K; Mündlein A; Drexel H; Mayhew CA; Leiherer A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():256-261. PubMed ID: 30537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS.
    Filipiak W; Sponring A; Baur MM; Ager C; Filipiak A; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    Microbiology (Reading); 2012 Dec; 158(Pt 12):3044-3053. PubMed ID: 23059976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile organic compounds in headspace characterize isolated bacterial strains independent of growth medium or antibiotic sensitivity.
    Hintzen KFH; Blanchet L; Smolinska A; Boumans ML; Stobberingh EE; Dallinga JW; Lubbers T; van Schooten FJ; Boots AW
    PLoS One; 2024; 19(1):e0297086. PubMed ID: 38277384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.